PIM1 inhibitors for use in treatment of viral infection and pharmaceutical compositions thereof
US12303515B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 2020 |
| Grant date | May 20, 2025 |
| Priority date | — |
| Expiry date | Aug 19, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A Pim-1 proto-oncogene, serine/threonine kinase (PIM1) inhibitor for use in the treatment of a viral infection or use of said PIM1 inhibitor in the preparation of a medicament for said treatment. A method of treating a human afflicted with a viral infection. The method comprises administering, to the human, an effective antiviral amount of a PIM1 inhibitor. A pharmaceutical composition for treating a viral infection comprising a PIM1 inhibitor and a pharmaceutically acceptable excipient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.